Mining
Business
Investments
Bitcoin
Trading
Markets
Blockchain
Home
»
Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study Transcript
Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study Transcript
September 2, 2026
September 2, 2026
Bitcoin (BTC)
$
77,294.00
Ethereum (ETH)
$
2,391.27
Tether (USDT)
$
0.99974
XRP (XRP)
$
1.35
BNB (BNB)
$
687.36
Dogecoin (DOGE)
$
0.081576
Solana (SOL)
$
99.56
USDC (USDC)
$
0.999824
Lido Staked Ether (STETH)
$
2,265.05
Avalanche (AVAX)
$
7.17
TRON (TRX)
$
0.324511
Wrapped stETH (WSTETH)
$
2,779.67
Sui (SUI)
$
0.73819
Chainlink (LINK)
$
11.08
WETH (WETH)
$
2,268.37
Polkadot (DOT)
$
0.858636